Anemia: A Nutritional and Natural Health Reference
Definition and Diagnostic Criteria
Anemia is a reduction in hemoglobin (Hb), hematocrit (HCT), or red blood cell (RBC) count. It is a condition that develops when blood produces a lower-than-normal amount of healthy red blood cells, depriving the body of sufficient oxygen-rich blood. Critically, anemia is not a diagnosis in itself, but a presentation of an underlying condition.
The World Health Organization (WHO) defines anemia as a hemoglobin level below 13 g/dL in males and below 12 g/dL in nonpregnant females. There are revised criteria for anemia related to chemotherapy, age, and race, and even "special populations" such as athletes, smokers, older adults, or those living at high altitudes have been reported to have different ranges.
Classification
Anemia is often subcategorized into microcytic, normocytic, and macrocytic based on mean corpuscular volume (MCV), a laboratory parameter that allows clinicians to formulate a practical diagnostic approach. The main mechanistic categories reflect three fundamental physiological disturbances:
- Blood loss (acute hemorrhage or chronic bleeding)
- Reduced red blood cell production (ineffective erythropoiesis)
- Increased red blood cell destruction (hemolysis)
The NIH's National Heart, Lung, and Blood Institute identifies these three major causes: acute or chronic blood loss, excessive blood cell destruction (hemolysis), and deficient red blood cell production (ineffective hematopoiesis).
Signs, Symptoms, and Affected Body Systems
Patients with anemia typically present with vague symptoms such as lethargy, weakness, and tiredness. The lack of oxygen can make a person feel tired or weak, and may also cause shortness of breath, dizziness, headaches, or an irregular heartbeat.
Whether or not a patient becomes symptomatic depends on the etiology, acuity of onset, and presence of comorbidities, especially cardiovascular disease. Most patients experience some symptoms when hemoglobin drops below 7.0 g/dL.
Several body systems are implicated in anemia's complications:
- Cardiovascular system: The cardiovascular system is most commonly affected in chronic anemia. Myocardial infarction, angina, and high-output heart failure are common complications, as are arrhythmias and cardiac hypertrophy.
- Nervous system: Severe anemia from a young age may lead to impaired neurological development in the form of cognitive, mental, and developmental delays.
- Musculoskeletal system: Severe iron deficiency is associated with restless leg syndrome and esophageal webs.
- Reproductive system: Pregnant women with anemia can go into premature labor and give birth to babies with low birth weight, and the condition also increases the risk of anemia in the baby and increased blood loss during pregnancy.
- Hematopoietic system: Erythropoietin (EPO), produced in the kidney, is the major stimulator of red blood cell production; tissue hypoxia is the major stimulator of EPO production, and levels of EPO are generally inversely proportional to hemoglobin concentration.
Epidemiology and Global Burden
Anemia affects a third of the world's population and contributes to increased morbidity and mortality, decreased work productivity, and impaired neurological development. In 2010, anemia accounted for 68.4 million years of life lived with disability, or 9% of the total global disability burden.
Young children, menstruating adolescent girls and women, and pregnant women are among the most vulnerable. Among children younger than 5 years, the most frequent cause of anemia is dietary iron deficiency, although haemoglobinopathies, other infectious diseases, and malaria are also important contributors in locations where these diseases are prevalent.
Contributing and Associated Factors
Nutritional Deficiencies
About 60% of the total global burden of anemia in 2019 was estimated to be due to dietary iron deficiency, making it the most significant cause of anemia-related disability. Deficiencies in vitamins A, B₂, B₆, B₁₂, C, D, E, folate, copper, selenium, and zinc can also result in anemia due to their specific roles in hemoglobin synthesis and/or erythrocyte production.
Infection and Inflammation
Chronic inflammation can disrupt iron handling, limiting its availability for red blood cell formation. In chronic inflammation, the liver produces high levels of hepcidin, a hormone regulating iron metabolism, leading to high ferritin levels and low transferrin saturation — a pattern known as "functional iron deficiency." In this condition, iron availability is restricted even when total body iron stores are adequate, contributing to anemia common in inflammatory bowel diseases and chronic infections.
Anemia of chronic disease (ACD) is a normochromic, microcytic anemia thought to be a consequence of the host defense response mediated by inflammatory cytokines (IL-6, IL-1, and TNF-α) that evolved to deprive bacteria of iron. Major pathophysiological processes underlying ACD include iron restriction, a blunted response to erythropoietin, and decreased red blood cell half-life.
Obesity and Metabolic Factors
Obesity is a chronic low-grade inflammatory condition, and it is postulated that this inflammation increases hepcidin, a regulator of iron homeostasis. Inflammatory cytokines associated with obesity — including TNF-α, IL-6, and CRP — directly promote hepcidin expression. Hepcidin is the main regulator of systemic iron homeostasis, restricting intestinal iron absorption and iron release from macrophages; patients with chronic diseases have higher hepcidin concentrations, causing decreased iron absorption and increased iron sequestration in the reticuloendothelial system, which results in anemia.
Non-communicable Diseases
Significant contributors to anemia include chronic diseases, infections like malaria and tuberculosis, and genetic disorders such as thalassemia and sickle cell disease. Non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and chronic kidney disease are increasingly recognized as significant contributors to anemia, with chronic inflammation and impaired erythropoiesis being key mechanisms linking these conditions.
Impaired Absorption
Additional mechanisms include impaired absorption — for example, lack of intrinsic factor to facilitate vitamin B₁₂ absorption, or high intake of inhibitors such as phytate that impair iron absorption — and nutrient interactions, such as vitamin A deficiency affecting the mobilization of iron stores.
Socioeconomic and Ecological Risk Factors
Anemia is the consequence of a wide range of causes, including biological, socioeconomic, and ecological risk factors. Primary causes include iron deficiency; inherited red blood cell disorders; infections such as soil-transmitted helminthiasis, schistosomiasis, and malaria; gynecological and obstetric conditions; and other chronic diseases. The most vulnerable population groups in low- and middle-income countries are often at greatest risk of suffering from several of these causes simultaneously, as low socioeconomic status is linked with increased risk of anemia through multiple pathways.
Key Nutrients in Relation to Anemia
Iron
Hemoglobin, an iron-rich protein, enables red blood cells to carry oxygen from the lungs to the rest of the body. There are two forms of iron found in foods: heme and nonheme. The average daily dietary iron intake is 10–15 mg in humans, yet only 1–2 mg is absorbed through the intestinal system.
Heme iron, principally found in meat as hemoglobin or myoglobin, is more readily and effectively absorbed than nonheme iron and thus provides a significantly greater dietary source of iron. Approximately 5–35% of heme iron is absorbed from a single meal, whereas nonheme iron absorption can range from approximately 2–20%, depending on the iron status of the individual and the ratio of enhancers and promoters in the diet.
The absorption rate of iron has been reported as 25–30% in the consumption of organ meats, 7–9% in green leafy vegetables, 4% in grains, and 2% in dried legumes. Ascorbic acid is a well-known dietary factor improving iron bioavailability; however, calcium, polyphenols, and phytates reduce intestinal iron absorption.
Bran fiber, large amounts of calcium particularly from supplements, and plant substances like phytates and tannins can inhibit the absorption of nonheme iron. Gastric acid plays an important role in the absorption of nonheme iron from the diet; proton pump inhibitors such as lansoprazole and omeprazole reduce the acidity of stomach contents and can reduce iron absorption.
Cooking food in iron cookware significantly increases its iron content. Studies have shown that iron content and absorption are 1.5 to 3.3 times higher when meats, vegetables, and legumes are prepared in iron pots, resulting in increased hemoglobin levels compared to those using non-iron vessels.
Vitamin B₁₂
Vitamin B₁₂ (cobalamin) deficiency causes the body to produce abnormally large red blood cells that cannot function properly — a condition classified as megaloblastic or macrocytic anemia. Vitamin B₁₂ performs several important functions in the body, including keeping the nervous system healthy.
A common cause of vitamin B₁₂ deficiency is pernicious anemia — an autoimmune condition where the immune system attacks healthy cells in the stomach, preventing the body from absorbing vitamin B₁₂ from food. Deficiency can also occur in those following a vegan diet who do not take B₁₂ supplements or eat fortified foods.
A clinical study of 420 adult patients with confirmed B₁₂ deficiency found that the most common clinical features were pallor (56.2%), fatigue (38.1%), anorexia (37.14%), and tingling sensations (32.14%), with anemia present in 75% of participants.
Claims that B₁₂ supplementation acts as an energy booster are based on the fact that correcting the megaloblastic anemia caused by B₁₂ deficiency should improve associated symptoms of fatigue and weakness. However, B₁₂ supplementation appears to have no beneficial effect on performance in the absence of a nutritional deficit.
Folate (Vitamin B₉)
Folate (vitamin B₉) deficiency, like B₁₂ deficiency, causes the body to produce abnormally large red blood cells that cannot function properly. Folate is critical for DNA synthesis and the proliferation of rapidly dividing cells, including erythroid precursors in the bone marrow.
An important clinical interaction is documented in NHANES data: anemia and cognitive impairment were observed approximately five times as often in individuals with the combination of low B₁₂ and high serum folate as in those with normal B₁₂ status and normal serum folate. The NIH ODS warns that large amounts of folate can correct the megaloblastic anemia, but not the neurological damage, that can result from vitamin B₁₂ deficiency, and some experts have been concerned that high intakes of folate supplements might mask vitamin B₁₂ deficiency until its neurological consequences become apparent.
Vitamin A
A meta-analysis of clinical trials demonstrated that vitamin A supplementation reduced the risk of anemia by 26% and increased hemoglobin levels compared to untreated groups. Current evidence indicates that the role of vitamin A in anemia pathogenesis is primarily associated with the regulation of erythropoiesis, modulation of iron metabolism, and enhancement of immune function to mitigate the risk of infection.
Copper
Copper is required for iron transfer from cells to blood, ensuring dietary iron absorption and systemic iron distribution. Excessive quantities of dietary zinc can impair copper absorption, leading to copper deficiency. A case documented in PMC illustrates this interaction: a patient with anemia due to zinc-induced copper deficiency was found to have an 18-year-old female with cerebral palsy admitted for respiratory failure; a bone marrow smear showed occasional ring sideroblasts, and additional testing revealed reduced serum copper and elevated serum zinc, consistent with several years of high-dose zinc supplementation. The report concludes it is important to consider copper deficiency as a potential etiology in patients with anemia and neutropenia, as it may otherwise be mistaken for vitamin B₁₂ deficiency or myelodysplasia.
Zinc
In early erythropoiesis, erythropoietin regulates erythrocyte precursor proliferation and survival via zinc finger transcription factors, and mature blood cell formation and functional activation are regulated by zinc-mediated hormones, vitamins, and growth peptides. In patients on hemodialysis, plasma zinc concentrations are decreased; zinc supplementation increases hemoglobin levels and reduces erythropoietin-stimulating agent treatments. However, inappropriate zinc supplementation causes copper deficiency.
Vitamin C (Ascorbic Acid)
Simultaneous intake of ascorbic acid increases absorption of iron. For example, a glass of orange juice or lime juice contains sufficient vitamin C to significantly increase iron absorption from foods. However, the direct effect on erythropoiesis is more nuanced: the impact of vitamin C on erythropoiesis does not appear to be homogeneous; it did not improve hemoglobin recovery in patients with iron-deficiency anemia, and in patients with sickle cell disease, the combined treatment of vitamin C and vitamin E increased markers of hemolysis.
Although iron, folate, and vitamin B₁₂ deficiencies are leading causes of anemia, deficiencies of micronutrients like vitamins other than B₁₂ and folate, as well as trace elements like selenium, zinc, and copper, can cause anemia in humans, although some of the evidence is derived from association studies and does not provide mechanistic data to support a causal relationship.
Herbs and Natural Ingredients: Traditional Use and Scientific Evidence
Stinging Nettle (Urtica dioica)
Traditional Use: Stinging nettle is an herb that has been used for more than 2,000 years as a natural remedy for a variety of conditions. It has been historically employed by European herbalists and in folk medicine for blood-building and the management of blood disorders. Nettle has traditionally been used in treating anemia, attributed to its iron content. Nettle leaf is considered a good source of easily assimilated iron, as well as vitamin A, vitamin C, magnesium, calcium, and potassium, along with antioxidants.
Scientific Evidence: Robust human clinical trials specifically isolating nettle's effect on hemoglobin are lacking in the peer-reviewed literature as of current evidence databases. Its value is attributed primarily to its nutrient profile — notably its combination of non-heme iron co-occurring with vitamin C, which may aid iron bioavailability. Alternative herbal preparations and supplements are promoted for the treatment of iron-deficiency anemia, but efficacy is unclear and safety varies. The evidence base for nettle specifically on anemia remains preliminary and largely observational.
Yellow Dock (Rumex crispus)
Traditional Use: Medieval European herbalists relied on yellow dock root as a primary remedy for blood disorders. Yellow dock has traditionally been used by adults in teas, alcohol extracts, and tinctures. Yellow dock has a long history of traditional use for iron support; it contains small amounts of iron as well as compounds that may help stimulate appetite and improve digestion.
Scientific Evidence: Yellow dock is known for its iron content and also contains anthraquinones, which are purported to promote iron absorption. However, controlled human clinical trials specifically assessing yellow dock's effect on anemia biomarkers are not well represented in the peer-reviewed literature. Yellow dock contains oxalate that can bind with calcium and form crystals in the kidneys; individuals who have or have had kidney stones should exercise caution. The herb may also interact with medications including digoxin, diuretic drugs, and warfarin. Evidence quality is low, based predominantly on traditional records and preliminary in vitro or animal data.
Spirulina (Arthrospira platensis)
Traditional Use: Spirulina, a blue-green microalgae, has been consumed as a food source for centuries in parts of Africa and Central America (notably by the Aztecs). Its modern use for anemia is largely a contemporary nutritional health practice rather than a deep ethnomedical tradition.
Scientific Evidence: This is one of the more-studied natural ingredients in relation to anemia. A 12-week open-label study of 40 senior adults (≥50 years) with no major chronic diseases enrolled to test Spirulina supplementation found that: over the 12-week study period, there was a steady increase in average values of mean corpuscular hemoglobin in subjects of both sexes; mean corpuscular volume and mean corpuscular hemoglobin concentration also increased in male participants; and older women appeared to benefit more rapidly. The investigators concluded that Spirulina may ameliorate anemia and immunosenescence in older subjects, and encouraged large human studies to determine whether this safe supplement could prove beneficial in randomized clinical trials. Limitations are significant: the study was small, uncontrolled (no placebo arm), and conducted in a specific older population.
The rationale for using Spirulina to correct anemia is based on its high content of iron with high bioavailability, content of porphyrin, and its content of phycocyanin which may boost the erythropoietic response. Animal testing and clinical studies, mostly uncontrolled, suggest a beneficial effect. However, controlled studies remain scarce. Overall, evidence quality for Spirulina and anemia is preliminary; no large, well-controlled RCTs have fully established efficacy.
Moringa (Moringa oleifera)
Traditional Use: In Ayurvedic tradition, moringa — called "Shigru" — was used for its exceptionally dense iron and vitamin C content to address conditions related to blood building. It has been used across South Asian and African traditional medicine systems as a nutritive food and herbal remedy.
Scientific Evidence: A pretest-posttest controlled study conducted in Indonesia (n=60 pregnant women, 30 per group) examined the effect of Moringa oleifera leaf capsules on hemoglobin in anemia during pregnancy. Hemoglobin levels in the moringa group increased by 1.743 mg/dL while they increased by 0.81 mg/dL in the control group, with a statistically significant result (p=0.000). This study is limited in design (non-randomized pretest-posttest), small sample, and was conducted in a single region of Indonesia, constraining generalizability. Evidence for moringa and anemia is preliminary, with most studies small and not double-blinded.
Ashwagandha (Withania somnifera)
Traditional Use: Ayurveda classified anemia as "Pandu Roga," a doshic imbalance primarily involving Pitta and Vata; practitioners used Ashwagandha to rebuild Ojas (vital essence) and support bone marrow function.
Scientific Evidence: Direct, well-powered clinical trials specifically examining Ashwagandha's effect on hemoglobin levels or anemia parameters are not well established in major peer-reviewed databases as of current evidence. Claims regarding its role in bone marrow support and reducing inflammation that contributes to anemia of chronic disease are largely theoretical or derived from general adaptogen research. Evidence is insufficient to draw clinical conclusions.
Dandelion (Taraxacum officinale)
Traditional Use: Dandelion has been used in both European and Native American herbal traditions as a general tonic, with the leaf and root used to support liver function and digestion, both of which can indirectly influence iron metabolism. Dandelion leaf contains iron and folate, both of which are involved in red blood cell production.
Scientific Evidence: Clinical trial data specifically evaluating dandelion supplementation on anemia outcomes are absent from the major peer-reviewed literature. Its theoretical relevance is based on its phytonutrient profile rather than controlled human studies. Evidence is anecdotal and traditional.
Dietary Patterns and Lifestyle Factors
Dietary Composition
Promoting access to iron-rich foods — such as meat and organs from cattle, fowl, fish, and poultry, and non-animal foods such as legumes and green leafy vegetables — alongside foods that enhance iron absorption (some fruits, vegetables, and tubers) is a foundational dietary strategy.
In populations following diets based on vegetable consumption with scarce meat intake — frequent in developing countries and also among vegetarians — in which iron is nonheme and iron deficiency is more likely, absorption may be increased by promoting the intake of foods that favor this (such as vitamin C) and avoiding those that hinder it (such as calcium, very fatty foods, and phytates).
The high prevalence of anemia in childhood is believed to result from a combination of increased iron requirements due to rapid growth and development and diets that are generally low in heme iron.
Plant-Based and Vegetarian Diets
Food items such as bran, wheat, soy, and other cellulosic products, which seemingly have no influence on heme iron absorption, tend to appreciably inhibit nonheme iron absorption, thus exposing vegetarians to a relatively greater risk of developing iron deficiency. Vegetarians and vegans therefore require deliberate dietary planning to optimize nonheme iron intake and absorption, including consistent pairing with vitamin C–containing foods and minimizing absorption inhibitors.
Obesity and Physical Activity
Obesity can be considered a chronic inflammatory state that can cause hyposideremia. Research in children and adolescents has documented a link between obesity and disrupted iron metabolism via the hepcidin pathway. An 8-month physical exercise intervention study at school found that: the exercise group showed decreases in BMI z-score, body fat mass, CRP, IL-6, ferritin, hepcidin, and soluble transferrin receptor, and an increase in iron concentration. This 8-month-long school-based intervention allowed a reduction in BMI z-score and an improvement in inflammation, reducing hepcidin levels and the disturbances in iron status. This suggests physical activity that reduces adiposity and systemic inflammation may support healthier iron metabolism.
Food Fortification
Prevention of iron deficiency lies in increasing dietary intake of iron. In regions where foods with high iron content are scarce, attempts are made to compensate by fortifying staple foods with iron; the effectiveness of this strategy is endorsed by multiple studies.
Medication and Drug Interactions with Dietary Iron
Iron tablets can interact with other prescribed drugs, making them less effective, including tetracycline, penicillin, ciprofloxacin, and drugs used for Parkinson's disease and seizures. In addition, medicines that reduce stomach acid will impair iron absorption, making iron supplements less effective.
Vulnerable Life Stages
Some people are at higher risk for anemia, including women during their menstrual periods and pregnancy. Several studies have indicated that the typical characteristics of anemic children include being under 2 years old, male, having low birth weight, reduced birth length, prematurity, having multiple siblings, and poor nutritional status. Factors contributing to reduced erythropoiesis efficiency in older adults include cellular senescence, genetic instability, telomere shortening, mitochondrial dysfunction, and altered intercellular communication.
Summary of Evidence Strength
- Strong (established) evidence: Iron, vitamin B₁₂, and folate deficiencies as causes of anemia; vitamin C enhancing nonheme iron absorption; phytates, polyphenols, and calcium inhibiting nonheme iron absorption; hepcidin as the central regulator of iron availability in inflammation.
- Moderate evidence: Vitamin A supplementation reducing anemia risk (meta-analysis data); copper's role in iron transport; zinc's role in erythropoiesis in specific populations (e.g., hemodialysis patients).
- Preliminary/weak evidence (small or uncontrolled studies): Spirulina for anemia in older adults; Moringa leaf in pregnant women with anemia in specific regional studies.
- Traditional use with insufficient clinical trial data: Stinging nettle, yellow dock, dandelion, and ashwagandha as herbal blood-builders — supported by historical and ethnobotanical records and plausible nutrient profiles, but lacking large, well-controlled human RCTs establishing efficacy for anemia specifically.
References
- Anemia — StatPearls, NCBI Bookshelf (NIH)
- Anemia — National Heart, Lung, and Blood Institute (NHLBI/NIH)
- Acute Anemia — StatPearls, NCBI Bookshelf (NIH)
- Hemolytic Anemia — StatPearls, NCBI Bookshelf (NIH)
- Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021 — The Lancet Haematology
- Accelerating action to reduce anemia: Review of causes and risk factors — PMC/NIH
- Global burden of anemia attributable to non-communicable diseases: GBD 2021 analysis — PMC/NIH
- Iron — Health Professional Fact Sheet, NIH Office of Dietary Supplements
- Iron — The Nutrition Source, Harvard T.H. Chan School of Public Health
- Optimal management of iron deficiency anemia due to poor dietary intake — PMC
- Iron Absorption: Factors, Limitations, and Improvement Methods — PMC
- Iron Deficiency Anemia — Nutrition Guide for Clinicians, PCRM
- Dietary Iron — StatPearls, NCBI Bookshelf (NIH)
- Vitamin B12 or folate deficiency anaemia — NHS UK
- Folate — Health Professional Fact Sheet, NIH Office of Dietary Supplements
- Folate–vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency — PMC
- Vitamin A, Vitamin D, Iron, and Zinc in Relation to Anemia Risk — PMC/NIH
- Role of Zinc and Copper in Erythropoiesis in Patients on Hemodialysis — Journal of Renal Nutrition
- Unusual Micronutrient Deficiencies as Causes of Anemia — MDPI Nutrients
- Anemia Due to Unexpected Zinc-Induced Copper Deficiency — PMC
- The Effects of Spirulina on Anemia and Immune Function in Senior Citizens — PMC
- Spirulina as a daily nutritional supplement in young Cambodian children — PMC/NIH
- Rethinking Iron Regulation and Assessment in Iron Deficiency, Anemia of Chronic Disease, and Obesity: Introducing Hepcidin — PMC
- Role of Hepcidin in the Pathophysiology and Diagnosis of Anemia — PMC
- The Association between Hepcidin and Iron Status in Children and Adolescents with Obesity — PMC/NIH
- Physical exercise intervention at school improved hepcidin, inflammation, and iron metabolism in overweight and obese children — Pediatric Research (Nature)
- Integrative Nutrition: Herbal Therapies to Treat Iron-Deficiency Anemia — Today's Dietitian
- Iron metabolism and iron disorders revisited in the hepcidin era — PMC
- Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries — CDC
Go back